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Abstract
Purpose The aim of this study was to identify structure and
language elements affecting the quality of responses from
Scandinavian drug information centres (DICs).
Methods Six different fictitious drug-related queries were sent
to each of seven Scandinavian DICs. The centres were blinded
for which queries were part of the study. The responses were
assessed qualitatively by six clinical pharmacologists (internal
experts) and six general practitioners (GPs, external experts).
In addition, linguistic aspects of the responses were evaluated
by a plain language expert.
Results The quality of responses was generally judged as sat-
isfactory to good. Presenting specific advice and conclusions
were considered to improve the quality of the responses.
However, small nuances in language formulations could affect
the individual judgments of the experts, e.g. on whether or not
advice was given. Some experts preferred the use of primary
sources to the use of secondary and tertiary sources. Both
internal and external experts criticised the use of abbrevia-
tions, professional terminology and study findings that was
left unexplained. The plain language expert emphasised the
importance of defining and explaining pharmacological terms
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to ensure that enquirers understand the response as intended.
In addition, more use of active voice and less compressed text
structure would be desirable.
Conclusions This evaluation of responses to DIC queries may
give some indications on how to improve written responses on
drug-related queries with respect to language and text struc-
ture. Giving specific advice and precise conclusions and
avoiding too compressed language and non-standard abbrevi-
ations may aid to reach this goal.
Keywords Quality assurance .Healthcare .Drug information
services . Information literacy
Introduction
To promote rational use of medicines, drug information cen-
tres (DICs) give advice on therapeutic drugs in response to
queries by health care professionals. The International
Pharmaceutical Federation (FIP) has recommended quality
assurance procedures like regular review of responses and
periodic review of resources and procedures for DICs.
However, easily applicable criteria for assessment of the qual-
ity of responses are not given [1]. No generally accepted qual-
ity criteria, nor guidance how to investigate these issues, exist
for DICs [2].
The Scandinavian DICs are regional centres affiliated with
units of clinical pharmacology at university hospitals. In
Norway, the centres receive funding from the Ministry of
Health and Care Services. In Sweden, centres are funded by
the county councils, and in Denmark, the individual university
hospital departments fund the centres. The centres produce
written responses to drug-related queries from health care pro-
fessionals [3–5]. To be able to use a response from a DIC in
patient treatment, it is essential that the enquirer has the ability
to read and understand both the language, content and specific
data (e.g. numeric study results) presented in the response, i.e.
has knowledge in drug information literacy [6] and numeracy
[7], respectively. These issues have been extensively studied
in the context of consumer information but may also apply for
information given to health care professionals [8]. With re-
spect to health care professionals, the practical usefulness of
the responses is important. As an example, a qualitative study
of the German Summary of Product Characteristics (SPCs)
concluded that physicians found them disorganised and diffi-
cult to use [9].
In the last few years, there has been an increasing focus on
the use of plain language in the information distributed by
public agencies [10–12], including health systems [13].
Plain language may be defined as the writing and setting
out of essential information in a way that gives a cooperative,
motivated person a good chance of understanding it at first
reading, and in the same sense that the writer meant it to be
understood [14]. In Sweden, the use of plain language is ac-
tually regulated by law [15]. In Norway, a project calledClear
language in Norway’s Civil Service was started in 2008 to
stimulate public agencies to adopt good, user-friendly lan-
guage [11]. Also, the Danish language council is committed
to this goal [16].
The principles for plain language are based on scientific
research; however, solutions how to achieve this goal are not
clear-cut [17]. Positive results have been reported from the
Norwegian Clear language in Norway’s Civil Service project
[18], although it is difficult to attribute the results to the spe-
cific project as such. Although DICs primarily serve health
care professionals, we do not know whether the use of cus-
tomized plain language may be preferable. Even though
health care professionals are familiar with medical terms, we
cannot automatically assume that they understand all informa-
tion in the responses. The text may be read in another context
than it was produced, and this may affect how the message is
interpreted [19]. Furthermore, some DICs, e.g. the Norwegian
centres, publish responses in generally accessible databases
and the users of these databases may have various knowledge
related to the topic. General understandability of the text is
therefore crucial.
The aim of this study was to assess the quality of written
responses from Scandinavian DICs to drug-related queries by
focusing on the qualitative aspects of the texts. Specifically,
we aimed to identify elements increasing or decreasing the
quality of written DIC responses, with emphasis on structure
and language elements.
Methods
Eleven Scandinavian DICs were presented with the protocol
for the study, and seven chose to participate. Staff members at
the centres were pharmacists and residents and consultants in
clinical pharmacology. Key information of the centres is given
in Table S1. We recruited 22 (three to four per DIC) general
practitioners (GPs) familiar with each of the DICs to simulta-
neously send six identical drug-related queries by e-mail to
each of the seven participating DICs. The queries (translated
to English) are presented in Table S2. Authors LAR, OS and
JS developed the queries in Norwegian. YB translated them to
Swedish, and HRC to Danish. Some adjustments between
countries were necessary (Table S2). The study period lasted
8 weeks from January to March 2013. The queries chosen
were typical for those usually received by the centres; they
had no clear-cut answers and concerned the most common
query categories, including adverse effects, drug use in preg-
nancy and lactation, drug interactions and choice of drug ther-
apy. Five queries were patient-specific and one was a more
general query (Table S2). The study was reported to the
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Norwegian Social Science Data Services in accordance with
national legislation.
Staff members at the participating DICs were informed
about the study but were blinded in terms of which queries
were study queries and which were not. The 42 responses
given, seven to each of the six queries, were anonymised for
which centre and staff member that had processed them. We
chose seven clinical pharmacologists (six of the authors: two
Norwegian, one Swedish and three Danish, and a second
Swedish clinical pharmacologist) within the DICs (internal
experts) to review the professional quality of responses. To
maintain blinding, none of the authors were involved in pre-
paring any of the responses to the study queries, or allocate
queries to specific staff members during the study period. In
addition, two Norwegian, two Swedish and two Danish GPs
(external experts) familiar with the DICs were chosen to re-
view the responses, as GPs are the most common group of
enquirers. Participating GPs each received NOK 10,000 for
their assessment. Their familiarity with the DICs would re-
duce the risk of misunderstandings related to the DICs’ role
and function. Finally, we chose to include a Norwegian exter-
nal plain language expert with a Master of Arts in Rhetoric, to
review the language quality of the written responses.
The internal and external experts individually reviewed all
42 responses and assessed the quality of them using a form
allowing quantitative scorings as well as qualitative com-
ments. The presentation of quantitative quality assessments
by internal and external medical experts in relation to time
consumption when processing the responses has been present-
ed in a separate article [20]. In the current article, we per-
formed a content analysis of and present examples of qualita-
tive comments made by the internal and external experts
concerning the strengths and weaknesses of the responses.
All experts were asked one specific overall question in the
assessment form, requiring them to answer with a qualitative
comment: Describe your assessment of concordance in prac-
tical advice and conclusions between responses from the var-
ious centres to the same query. Specifically: Did the documen-
tation found and/or advice given differ between responses? In
addition, qualitative comments of any kind were encouraged
for each of the individual 42 responses. The degree to which
individual experts commented varied largely, but 10 (six in-
ternal and four external) of the 12 experts commented regu-
larly on many aspects of the responses.
Analysis of qualitative statements
The author LAR manually reviewed and categorized com-
ments into three main groups reflecting central themes in the
comments: (i) presentation of background documentation and
references/enclosed literature, (ii) provision of advice/
conclusions and (iii) the use of definitions of concepts/
explanation of abbreviations. Another author (JS) reviewed
the categorization of comments. The condensation and selec-
tion of data and the selection of quotes presented was based on
agreement between LAR and JS. A third author (OS) was
consulted in case of controversy.
Assessment of language quality
To evaluate the language quality of the responses, we
contacted a company specializing in plain Scandinavian lan-
guages and involved in Clear language in Norway’s Civil
Service [11]. The recruited Norwegian plain language expert
had experience in evaluation of texts in all Scandinavian lan-
guages. A pilot study was performed, using six drug-related
queries and responses taken from the Norwegian, Swedish
and Danish DIC databases. The aim of the pilot study was to
formulate relevant language quality criteria to assess the
DICs’ responses, account for important professional and
methodological caveats of the study and test the quality
criteria on the basis of the findings. Eight quality criteria were
compiled (Table 1). The plain language expert explained the
background for each of them and used the criteria to assess the
quality of the 42 responses. The expert evaluated responses
written in Norwegian, Swedish and Danish. As one of the
DICs presented their main responses in English, the prelimi-
nary responses (written in Danish) were assessed for this cen-
tre. The eight language criteria could be scored from 0
(poorest quality) to 4 (highest quality), and these scores were
added giving a total score between 0 (lowest quality) and 32
(highest quality) per response.
Results
The material assessed in this study consisted of 42 responses
to the six queries. Extra documents were enclosed in 12 re-
sponses. Of these attached documents (n = 21), nine were
former responses given by the DICs, seven were review arti-
cles, two were treatment recommendations, two were infor-
mation obtained from drug information databases and one was
an original article. The external and internal experts assessed
all documents, whereas the plain language expert mainly
assessed the written responses specific to the queries. We did
not identify differences between the external and internal ex-
perts concerning the central themes and the assessment of
responses; therefore, the results from the medical experts’
evaluations are presented together.
Assessment by medical experts
A total of 334 comments were given. Table 2 presents exam-
ples of specific comments given by the internal and external
experts to characterize elements of the responses affecting
their quality. Table 3 shows the results of our analyses of
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characteristics that seem to increase or decrease the assessed
quality of the responses. Examples illustrating the three main
themes are given below.
Presentation of background documentation
and references/enclosed literature
With a few exceptions, the experts judged the pharmacologi-
cal content in the responses to be concordant. Responses to the
same query grossly differed in some instances in the number
and types of references included. Both internal and external
experts commented on this issue. For the responses to one
query, an external expert stated: The background documenta-
tion found seems to be relatively similar between centres be-
cause the same adverse effects and precautions are men-
tioned. However, the responses vary in terms of the use of
primary and secondary articles. Several experts introduced
the terms Bweak^ and/or Bthin^ references. Although the
terms were not further explained, they were used for responses
referring tomainly or only, secondary and tertiary sources, e.g.
the Summary of Product Characteristics (SPCs) and drug in-
teraction databases. None of the experts explicitly stated that
they preferred the use of primary references; however, one of
the internal experts stated: Secondary literature is used as
references; sometimes they [i.e. the DICs] only refer to former
responses to queries at the DIC. When is this appropriate?
None of the responses gave an overview over all articles that
had been reviewed preparing the response. Thus, the experts
were not aware of whether staff members preparing responses
to the same query actually reviewed the same evidence, but
ultimately chose to refer to different sources.
Provision of advice/conclusions
Both internal and external experts were concerned whether
specific conclusions and/or advice were given, and seem to
expect rather specific advice on how to handle the cases, es-
pecially for the patient-specific queries. There were large dif-
ferences between responses in terms of whether or not advice
was given and if given, how specific it was. Both external
and internal experts commented on the lack of concordance.
As an example, one of the external experts stated that the
responses to one query varied extensively in their ability to
draw conclusions relevant for practice. Small variations in
language could result in different assessments on whether or
not an advice was given. For example, a recommendation to
Table 1 Criteria used to describe the quality of structure and language elements of written responses from Scandinavian drug information centres
(DICs) to six fictitious queries (six queries were sent to each of seven different DICs)
Criteria no. Criteria Mean score
(min to max)
Median score
(0–4)
Comment
1 Does the response have a distinct structure? 3.1 (2 to 4) 3 The purpose of the structure is to help the reader get an
overview, sort information and point out the more
important parts of the response. The use of e.g. captions
and paragraphs will help the reader to sort out information.
2 Are words and concepts used in the
query, also repeated in the response?
2.5 (1 to 4) 3 The use of similar words and concepts in the response, as
in the query, will lead to continuity and consistency.
The repetition and explanation will increase the
likelihood that the writer and the reader understand
each other.
3 Are words and concepts explained or
defined? Are other words used to
explain them?
2.5 (1 to 4) 3
4 Is the response written in an abstract or
concrete style?
2.4 (1 to 3) 2.5 Very compressed texts may be more difficult to read and
understand, and the use of words to make the text less
compressed is preferred. One fact should be presented
at a time. The use of active (Bwe assume this is caused
by^) instead of passive (Bit is assumed that this is caused
by^) formulations is also preferred. This does not mean
one have to be personal in his style, but a direct tone
will make it easier for the reader to know exactly what
action he/she should take.
5 Does the use of pronouns, verbs and
dependent clauses help making the
text less compressed?
2.5 (0 to 4) 3
6 Is it easy for the reader to understand
who should perform the described
actions?
2.4 (0 to 3) 2
7 Are answers to the query given scattered
or as one common conclusion?
2.8 (1 to 4) 3 Is the query interpreted correctly, and all parts of the query
responded to? It is crucial that the answer to the query
is given in a conclusion. This is particularly important
if the staff member has discussed several possible
solutions and advice along the response. A conclusion
in the end of a response has the benefits of summarizing
the knowledge, and possibly, clarifying potential
misunderstandings.
8 Is it easy to find a concrete answer
to the query?
2.9 (1 to 4) 3
The quality criteria were developed by a plain language expert with a Master of Arts in Rhetoric and are based on plain language theory [14]. Each
criterion was scored from 0 (poorest quality) to 4 (highest quality)
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consider discontinuing diazepam was assessed less precise
than we recommend discontinuing diazepam. In one written
response, the following conclusion was given: BWe have not
found any documentation implying that discontinuation of
treatment is necessary.^ In relation to this, several experts
commented that the staff member preferably should have stat-
ed that the recommendation was to continue treatment.
The use of definitions of concepts/explanation
of abbreviations
Both expert groups gave many examples of medical and phar-
macological terms and/or abbreviations that they felt should
be explained more thouroughly in the responses. For example,
terms like double-dummy, drug holiday, confounding by
indication, weight-adjusted dosage, stereochemistry, and ab-
breviations like SNRI, PPHN, Cmax, tmax and AUC were used
without further explanation. One external expert stated: I do
not understand this weight-adjusted dosage. Should I do
something? and How do you know whether the mother of
the baby is a Brapid acetylator^? Several experts further
criticised the lack of translation of study findings into clinical-
ly meaningful information. One internal expert stated: The
solubility in water and ethanol is mentioned without
commenting the significance of fat solubility on the degree
of absorption. The presentation of results from animal studies
lacking generalizability to humans was also criticised.
Assessment by the plain language expert
The plain language expert emphasised the importance of the
responses giving competent and clear answers to the queries.
The enquirer should theoretically be able to understand and
use the response in an appropriate way in the treatment of a
specific patient. The plain language expert did not identify
features that gave her reason to believe that the responses
did not fulfil these intentions. However, the expert pointed
out that there was room for improvement. The expert took into
Table 2 Examples of comments given by internal (clinical
pharmacologists) and external (general practitioners) experts to assess the
quality of 42 responses to drug-related queries (six fictitious queries posed
to seven Scandinavian drug information centres (DICs)). Comments relat-
ing to all responses are named general comments. Comments relating to
one specific response are named specific comments.
Comments related to aspects increasing the
quality of responses
Comments related to aspects decreasing the quality of responses
Internal experts • Enclosed articles should be Bto the point^, highly relevant
and not too demanding for the enquirer to read (expert E,
general comment).
• Systematic and well-documented response that results in
specific advice (expert G, specific comment).
• Very thorough and deepened response with a review of
primary literature. It depends on your preferences whether
this is necessary, but the conclusion is precise (expert G,
specific comment).
• The best responses give specific and practically oriented
answers, while the poorest ones give more floating,
indirect answers like Bstudies have not shown etc.^
Should you – or should you not! – that is the question!!
(expert H, general comment).
• Generally, I feel it is Bbad service^ to write very short
and then refer to many enclosed articles in an un-prioritized
order. Then the enquirer has to find the answer himself,
especially when the enclosed articles have different
conclusions (expert F, general comment).
•One response distinguishes itself from the others with inadequate
background information, even though it is possible that the
response is based on literature and sources that are not referred
to (expert I, specific comment).
• I miss a summary; this makes it difficult to get an overview of
the response (expert J, specific comment).
• This response does not contain anything that resembles a specific
advice. The sentence Bshould be assessed based on a clinical
risk-benefit assessment^ is a triviality. Is not this always true??
(expert G, specific comment)
External
experts
• The response is concise. It does not contain unnecessary
details, and is presented with a clear conclusion that is
logical and practical and useful (expert A,
specific comment).
• Well-done and thorough review of all drugs involved.
A clear, sensible and practically useful conclusion too.
The response witnesses considerable clinical insight.
(…) Good argumentation and (…) some background
information that supports the given advice (expert A,
specific comment).
• (…) Since the responses are supposed to be relevant for
clinicians, it is important that the centres have good and
transparent routines for collection of evidence, and that
it is possible to view the documentation. At the same
time, advice must provide the basis for clinical
decision-making. (…) (expert C, general comment).
• To me, it is crucial that they dare making a specific
decision (expert D, general comment).
• All responses conclude that the evidence is sparse, but not all of them
dare to draw a useful conclusion, and that is what you are lacking as
a physician, whom is supposed to use the answer. The physician has
to make a decision (expert B, general comment).
• The conclusion is to Bbe cautious^. This is your starting point when
you ask for advice (…) (expert C, specific comment).
• If you enclose an article, it is important to comment WHETHER and
WHAT the enquirer should read that gives him/her supplementary
information to the response, otherwise you should not enclose
it (expert B, specific comment).
• Several kinds of advice on possible measures of action are given,
but no prioritization or concrete order is suggested. That may
be correct, because no Bperfect^ answer exist. However, I would
prefer that they were more concrete, e.g. suggested one or two
measures to be tried first (expert A, specific comment).
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account the fact that the communication took part between
health care professionals. However, the expert argued that al-
though themedical content is familiar for both parties, repeating
or recapitulating information could nevertheless increase the
easiness of reading the text—and thereby enhance the under-
standing of the response. This procedure ensures a common
understanding of the content between the staff members and
the readers (enquirers, or in this case, expert medical reviewers).
Table 1 shows the mean, median, minimum and maximum
score of each of the eight language quality criteria, as well as
arguments for including the specific criteria. The mean sum
score per response was 21.1 (65.9%) out of a maximum of 32.
Figure S1 depicts the distribution of sum scores for each of the
responses.
Discussion
The results from the present study indicate that the quality of
structure and language of responses to drug-related queries in
Scandinavian DICs is by and large satisfactory to good. Still,
there is room for further improvements. The analysis of the
experts’ assessments has added to our understanding of ele-
ments affecting the quality of these responses. In particular,
the majority of experts emphasised the importance of giving
specific, evidence-based advice, and relatively small nuances
in expressions between responses may have resulted in differ-
ent interpretations in terms of whether advice was specific or
not. The use of phrases like Bbe cautious^ and Bperform a risk-
benefit assessment^ (Table 3), in the lack of more specific
information on how to handle a situation, may not be useful
for the clinician. Most queries posed to Scandinavian DICs are
patient-specific [21], and information given in the responses
needs to be applied to the particular case [2] and be operation-
al. Scandinavian DICs include a staff of pharmacists and res-
idents and consultants in clinical pharmacology with educa-
tion and training in literature search, interpretation of pub-
lished studies and experience with provision of decision sup-
port. The desire for specific advice among our external experts
might be interpreted as a vote of confidence in the DICs. It is
important, however, that working methods are transparent so
that the enquirer may assess whether a given advice is in
accordance with the existing and presented literature.
There seem to be different opinions among the experts as to
whether it is sufficient to use secondary/tertiary sources and
formerly answered queries to produce responses, as opposed
to primary articles; however, this issue needs to be further
investigated. The use of appropriate and credible sources
along with critical literature evaluation skills [2] may be more
important than exactly what type of source is used. The great
workload of some centres may limit their ability to scrutinise
the primary literature, as this kind of searching is time
Table 3 Characteristics increasing and decreasing the quality of responses from drug information centres (DICs)
Characteristics increasing the quality of responses
Presented data Advice and conclusions References/enclosed articles
• Correct
• Relevant to the query
• Clinical relevance interpreted and
commented
• All parts of a query answered
• Synthesized (Bdigested^)
• Abbreviations, definitions and concepts
explained
• States whether an updated literature
search has been done
• Logical structure
• Specific, clear and useful advice
• Backgrounds/arguments for advice should be
discussed
• In accordance with the cited literature and
presented data
• If relevant, help the enquirer prioritize
• Evidence-based
• Problem-solving
• References should be presented precisely for all
facts
• Up-to-date
• The Bmost important^ found (e.g. new original
articles)
• For additional information
• Enclosed articles are introduced and act as
supplementary information, only – the enquirer is
not required to read them
• The content of the enclosed articles should present
specific and pinpointed information
Characteristics reducing the quality of responses
Presented data Advice and conclusions References
• General information not directly relevant
to the query
• Query not answered
• Oxymoron, especially in the lack of an
conclusion
• Facts presented without interpretation of
clinical significance or advice on Bwhat
to do^ with the information
• Incorrect statements or interpretation of
literature
• Presenting advice without argumentation or
scientific basement
• BBe cautious^ as the only advice
• Risk-benefit assessment left to enquirer without
further advice
• Conclusions section lacking in longer responses
• Enclosed articles without any further
presentation/information
• Use of case reports and animal studies, especially
without interpreting their clinical relevance
The characteristics are based on review of qualitative statements made by external (general practitioners) and internal (clinical pharmacologists) experts
evaluating 42 responses to queries posed to seven Scandinavian drug information centres (DICs). Note that this is based on their individual comments,
and that no consensus has been reached among the experts, concerning these characteristics
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consuming [21, 22]. Especially for frequently asked queries
where the evidence is comprehensive, e.g. use of antidepres-
sants during pregnancy and lactation, the use of secondary and
tertiary sources may be preferable from the staff members’
point of view. However, to ensure the responses being up-to-
date, it is important to search for recently published primary or
review articles.
Both expert groups commented on the lack of explanation
of medical terms and abbreviations. Several external experts
specifically mentioned medical terms (e.g. weight-adjusted
dosage) that they did not understand the meaning of, and
therefore did not know how to handle. A potential problem
sending written responses to enquirers without verbal commu-
nication is the lack of assurance that the information and/or
advice are interpreted as intended. Readers are individuals
[23], and texts are read in another context than they are written
[19]. Several experts criticised the lack of translation of study
findings into clinically meaningful information. Rather than
just cite sources passively, they recommended commenting
and explaining data and results with regard to individual pa-
tient treatment and clinical practice. This suggests that it is
important for DICs to maintain and develop this type of com-
petence among the staff.
In addition to the explanation of medical and pharmacolog-
ical terms and abbreviations, the plain language expert pre-
sented and assessed several factors that may contribute to
better readability of the responses, all based upon plain lan-
guage theory (Table 1) [10, 14]. The plain language method
implies adjusting written information to the recipients’ need,
structure the document clearly, use informative headings, ap-
ply active voice and explain difficult, but necessary words.
The aim is to ensure that the most important informational
content is identified and understood by the reader as intended
by the author of the document [14]. Interestingly, responses
that did well in the medical experts’ analyses did not neces-
sarily score high in the language assessment and vice versa.
Especially, our medical experts did not seem to pay much
attention to the criteria 2, and 4 to 6 (Table 1). The lowest
scores in the assessment of language quality were given for
features that may relate to the DICs scientific style in writing,
e.g. the use of passive voice instead of active, which is a
common style for writing scientific articles. In addition, writ-
ing a scientific text often encompasses the need to reduce the
number of words, thereby compressing the language. Whether
writing more plain language actually is necessary for
enquirers and staff members to understand each other is un-
known. Although not all criteria may be useful in relation to
the DICs’ responses, the present study underlines the impor-
tance of precise formulations, e.g. in relation to giving advice.
It may not be advisable to leave to the enquirer to understand
and interpret what is more or less implicitly stated in a text.
Although the number of previous studies within this field is
scarce, several of the issues pointed out in this article have
been mentioned by the UK Medicines Information Centres
in their BGuide to writing medicines Q & As^ [24] and check-
lists for quality assurance of queries and answers [25] avail-
able online. Included in the checklist is that the information
given should be concise and presented in a logical order, no
unreferenced key statements should exist, the summary
should reflect key points accurately and completely, no mis-
takes should be made in the referencing, and a primary liter-
ature search (including the use of Embase/Medline) should
always be performed [25].
Strengths and limitations
No studies have previously published results from quality as-
sessments of written DIC responses using qualitative data and
assessment by a plain language expert. Although identical
queries were posed to the centres, we did not expect seven
identical responses to each of these. Each centre has its Bstyle^
and working methods (Table S1), and this clearly affected the
responses. In addition, the choice of literature to refer to, in-
terpretation of documentation and the exact structure and
wording of the response are examples of working procedures
that cannot be 100% similar between individual staff mem-
bers. The lack of concordance between DIC responses in
terms of advice illustrates the difficulties in streamlining the
preparation of these responses. However, this lack of concor-
dance was also very useful, as we thereby could identify a
potentially important quality criterion in DICs’ responses; to
give specific, clinically useful advice.
The method for collecting the data required that internal and
external medical experts supplied written comments. As such,
one might criticise the level of systematic data collection.
Surely, experts contributed in a variable degree to the qualitative
comments.Moreover, most comments represented the opinion of
single experts and no attempt was made to reach consensus
among the experts with this respect. Our external experts may
not be representative for the average user of the Scandinavian
DICs, as they were familiar with and perhaps had an inherent
positive attitude to the DICs. In addition, the monetary incentive
may have introduced a bias, as the external experts may have felt
obligated to judge the responses better than they otherwise
would. However, the assessment of responses was quite time
consuming, and we feared we would not be able to recruit GPs
for this task without any financial reward.
The wording of the only query in the assessment form specif-
ically formulated for qualitative information may have increased
the experts’ focus on advice and conclusions, and introduced a
bias. The experts reviewed responses to prefabricated study
queries rather than self-provided queries, and the comparison of
several responses to the same query might have made them
especially strict in their assessments. However, it may also have
helped them realise what the essential factors in the Bbest
responses^ actually were, which was our intention.
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We focused on written responses only, because all the in-
cluded DICs produce written responses to most queries.
However, some of the centres give oral responses by tele-
phone instead and/or in addition. Quality-assuring verbal re-
sponses would require tape-recording of telephone calls, with
an increasing possibility of violation of the blinding. In this
study, we have no confirmation that unblinding took place, but
some DICs and staff members did express suspiciousness to-
wards some queries. This may have caused them to respond
more thoroughly to these queries than they otherwise would
have done.
We posed only six queries to the DICs during this study.
Although these were typical for the centres included, mainly
patient-specific, the responses may not be representative for
all the responses given. Nevertheless, the importance of this
study does not necessarily lie in the quality of each response,
but in the possibility to compare different responses to the
same query against each other.
Our plain language expert usually works with texts
intended for lay people and had to do some adjustments when
working with DIC responses. The responses are specific an-
swers to unique, mostly patient-related queries, rather than
general information. Therefore, the expert did not assess the
necessity of an introduction, background information and re-
ferral to further information, as normally would have been
done. The Norwegian plain language expert had experience
in evaluation of both Swedish and Danish language. The prin-
ciples of plain language are generally the same for all three
languages, but being Norwegian, we cannot rule out that the
expert may have been biased in the evaluation of texts in the
three different languages. Due to the cost of the language
evaluation, we limited the assessment to one expert only and
the scores of the language criteria are based on qualitative
assessments. Applying an assessment of the language in these
responses have extended and improved our understanding of
the importance of structure and language style in these re-
sponses, although we may not feel that all criteria, e.g. the
use of active voice, were suitable for our context.
Conclusion
The quality of structure and language of responses to drug-
related queries posed to seven Scandinavian DICs was gener-
ally satisfactory to good. Improvements suggested by medical
and language experts include providing specific advice on
action, and presenting and defining professional terms and
abbreviations in order to increase both the readability and
the understanding of the responses.
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